EEXASEXACT Sciences Corporation

EXACT Sciences Corporation

EXAS

1D · 1W · 1M · 3M · YTD · 1Y · 5Y · AllLive EXAS chart

  • Mkt cap

    $20.03B

  • EV/Sales

    5.87

  • P/E ratio

    N/A

  • FY2025 Revenue

    $3.25B

  • EPS (9mo ended 2025-09-30)

    $-0.65

  • Gross Margin (FY2025)

    69.69%

  • Profit Margin (FY2025)

    -6.40%

  • Beta

    N/A

  • Div yield

    N/A

  • Sector

    Healthcare

No recent filings in cache.

Live EXAS terminalLician Pro · $19.99/mo or $149/yrPeer financials on ProAPI free 100/dayCompare AAPL vs MSFT

EXAS — EXACT Sciences Corporation · rev $3.25B

EXAS Key Statistics

  • Market Cap: $20.03B
  • P/B Ratio: 8.34

EXACT Sciences Corporation latest statements (FY2025)

Latest cached year on this hub. Full EXAS income, balance, and cash tables.

  • Revenue$3.25B
  • Net Income-$207.9M
  • Total Assets$5.86B
  • Free Cash Flow$356.8M

EXAS FAQ

What industry is EXAS in?

EXACT Sciences Corporation (EXAS) is a diagnostics & research company in the Healthcare sector.

What are EXAS's latest revenue and net income?

Latest cached EXACT Sciences Corporation (EXAS) revenue for Dec 31, 2025 was $3.25B. Net income was -$207.9M. Statements: https://lician.com/financials/exas

What is EXAS's market cap?

EXACT Sciences Corporation (EXAS) market capitalization is $20.03B on the latest cached snapshot.

Live EXAS terminal loads when you scroll near this section.